Market Analysis and Insights: Global BioPharma Service Market
The global BioPharma Service market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of BioPharma Service include Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek and SGS, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for BioPharma Service market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of BioPharma Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for BioPharma Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the BioPharma Service revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global BioPharma Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for BioPharma Service revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek and SGS, etc.
By Company
Eurofins
Pace Analytical Services
Catalent
Envigo
PPD
Element
ALS
Intertek
SGS
Boston Analytical
EAG
Maxxam
ARL Bio Pharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Segment by Type
Raw Material
In-Process and Product
Finished Pharmaceutical
Others
Segment by Application
Analytical Testing
Drug Development Service
Drug Packaging and Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of BioPharma Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioPharma Service companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BioPharma Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BioPharma Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Raw Material
1.2.3 In-Process and Product
1.2.4 Finished Pharmaceutical
1.2.5 Others
1.3 Market by Application
1.3.1 Global BioPharma Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Analytical Testing
1.3.3 Drug Development Service
1.3.4 Drug Packaging and Delivery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioPharma Service Market Perspective (2018-2029)
2.2 Global BioPharma Service Growth Trends by Region
2.2.1 BioPharma Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 BioPharma Service Historic Market Size by Region (2018-2023)
2.2.3 BioPharma Service Forecasted Market Size by Region (2024-2029)
2.3 BioPharma Service Market Dynamics
2.3.1 BioPharma Service Industry Trends
2.3.2 BioPharma Service Market Drivers
2.3.3 BioPharma Service Market Challenges
2.3.4 BioPharma Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue BioPharma Service by Players
3.1.1 Global BioPharma Service Revenue by Players (2018-2023)
3.1.2 Global BioPharma Service Revenue Market Share by Players (2018-2023)
3.2 Global BioPharma Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of BioPharma Service, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global BioPharma Service Market Concentration Ratio
3.4.1 Global BioPharma Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioPharma Service Revenue in 2022
3.5 Global Key Players of BioPharma Service Head office and Area Served
3.6 Global Key Players of BioPharma Service, Product and Application
3.7 Global Key Players of BioPharma Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 BioPharma Service Breakdown Data by Type
4.1 Global BioPharma Service Historic Market Size by Type (2018-2023)
4.2 Global BioPharma Service Forecasted Market Size by Type (2024-2029)
5 BioPharma Service Breakdown Data by Application
5.1 Global BioPharma Service Historic Market Size by Application (2018-2023)
5.2 Global BioPharma Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America BioPharma Service Market Size (2018-2029)
6.2 North America BioPharma Service Market Size by Type
6.2.1 North America BioPharma Service Market Size by Type (2018-2023)
6.2.2 North America BioPharma Service Market Size by Type (2024-2029)
6.2.3 North America BioPharma Service Market Share by Type (2018-2029)
6.3 North America BioPharma Service Market Size by Application
6.3.1 North America BioPharma Service Market Size by Application (2018-2023)
6.3.2 North America BioPharma Service Market Size by Application (2024-2029)
6.3.3 North America BioPharma Service Market Share by Application (2018-2029)
6.4 North America BioPharma Service Market Size by Country
6.4.1 North America BioPharma Service Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America BioPharma Service Market Size by Country (2018-2023)
6.4.3 North America BioPharma Service Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe BioPharma Service Market Size (2018-2029)
7.2 Europe BioPharma Service Market Size by Type
7.2.1 Europe BioPharma Service Market Size by Type (2018-2023)
7.2.2 Europe BioPharma Service Market Size by Type (2024-2029)
7.2.3 Europe BioPharma Service Market Share by Type (2018-2029)
7.3 Europe BioPharma Service Market Size by Application
7.3.1 Europe BioPharma Service Market Size by Application (2018-2023)
7.3.2 Europe BioPharma Service Market Size by Application (2024-2029)
7.3.3 Europe BioPharma Service Market Share by Application (2018-2029)
7.4 Europe BioPharma Service Market Size by Country
7.4.1 Europe BioPharma Service Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe BioPharma Service Market Size by Country (2018-2023)
7.4.3 Europe BioPharma Service Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China BioPharma Service Market Size (2018-2029)
8.2 China BioPharma Service Market Size by Type
8.2.1 China BioPharma Service Market Size by Type (2018-2023)
8.2.2 China BioPharma Service Market Size by Type (2024-2029)
8.2.3 China BioPharma Service Market Share by Type (2018-2029)
8.3 China BioPharma Service Market Size by Application
8.3.1 China BioPharma Service Market Size by Application (2018-2023)
8.3.2 China BioPharma Service Market Size by Application (2024-2029)
8.3.3 China BioPharma Service Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia BioPharma Service Market Size (2018-2029)
9.2 Asia BioPharma Service Market Size by Type
9.2.1 Asia BioPharma Service Market Size by Type (2018-2023)
9.2.2 Asia BioPharma Service Market Size by Type (2024-2029)
9.2.3 Asia BioPharma Service Market Share by Type (2018-2029)
9.3 Asia BioPharma Service Market Size by Application
9.3.1 Asia BioPharma Service Market Size by Application (2018-2023)
9.3.2 Asia BioPharma Service Market Size by Application (2024-2029)
9.3.3 Asia BioPharma Service Market Share by Application (2018-2029)
9.4 Asia BioPharma Service Market Size by Region
9.4.1 Asia BioPharma Service Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia BioPharma Service Market Size by Region (2018-2023)
9.4.3 Asia BioPharma Service Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America BioPharma Service Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America BioPharma Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America BioPharma Service Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America BioPharma Service Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America BioPharma Service Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America BioPharma Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America BioPharma Service Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America BioPharma Service Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America BioPharma Service Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America BioPharma Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America BioPharma Service Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America BioPharma Service Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America BioPharma Service Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Details
11.1.2 Eurofins Business Overview
11.1.3 Eurofins BioPharma Service Introduction
11.1.4 Eurofins Revenue in BioPharma Service Business (2018-2023)
11.1.5 Eurofins Recent Developments
11.2 Pace Analytical Services
11.2.1 Pace Analytical Services Company Details
11.2.2 Pace Analytical Services Business Overview
11.2.3 Pace Analytical Services BioPharma Service Introduction
11.2.4 Pace Analytical Services Revenue in BioPharma Service Business (2018-2023)
11.2.5 Pace Analytical Services Recent Developments
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent BioPharma Service Introduction
11.3.4 Catalent Revenue in BioPharma Service Business (2018-2023)
11.3.5 Catalent Recent Developments
11.4 Envigo
11.4.1 Envigo Company Details
11.4.2 Envigo Business Overview
11.4.3 Envigo BioPharma Service Introduction
11.4.4 Envigo Revenue in BioPharma Service Business (2018-2023)
11.4.5 Envigo Recent Developments
11.5 PPD
11.5.1 PPD Company Details
11.5.2 PPD Business Overview
11.5.3 PPD BioPharma Service Introduction
11.5.4 PPD Revenue in BioPharma Service Business (2018-2023)
11.5.5 PPD Recent Developments
11.6 Element
11.6.1 Element Company Details
11.6.2 Element Business Overview
11.6.3 Element BioPharma Service Introduction
11.6.4 Element Revenue in BioPharma Service Business (2018-2023)
11.6.5 Element Recent Developments
11.7 ALS
11.7.1 ALS Company Details
11.7.2 ALS Business Overview
11.7.3 ALS BioPharma Service Introduction
11.7.4 ALS Revenue in BioPharma Service Business (2018-2023)
11.7.5 ALS Recent Developments
11.8 Intertek
11.8.1 Intertek Company Details
11.8.2 Intertek Business Overview
11.8.3 Intertek BioPharma Service Introduction
11.8.4 Intertek Revenue in BioPharma Service Business (2018-2023)
11.8.5 Intertek Recent Developments
11.9 SGS
11.9.1 SGS Company Details
11.9.2 SGS Business Overview
11.9.3 SGS BioPharma Service Introduction
11.9.4 SGS Revenue in BioPharma Service Business (2018-2023)
11.9.5 SGS Recent Developments
11.10 Boston Analytical
11.10.1 Boston Analytical Company Details
11.10.2 Boston Analytical Business Overview
11.10.3 Boston Analytical BioPharma Service Introduction
11.10.4 Boston Analytical Revenue in BioPharma Service Business (2018-2023)
11.10.5 Boston Analytical Recent Developments
11.11 EAG
11.11.1 EAG Company Details
11.11.2 EAG Business Overview
11.11.3 EAG BioPharma Service Introduction
11.11.4 EAG Revenue in BioPharma Service Business (2018-2023)
11.11.5 EAG Recent Developments
11.12 Maxxam
11.12.1 Maxxam Company Details
11.12.2 Maxxam Business Overview
11.12.3 Maxxam BioPharma Service Introduction
11.12.4 Maxxam Revenue in BioPharma Service Business (2018-2023)
11.12.5 Maxxam Recent Developments
11.13 ARL Bio Pharma
11.13.1 ARL Bio Pharma Company Details
11.13.2 ARL Bio Pharma Business Overview
11.13.3 ARL Bio Pharma BioPharma Service Introduction
11.13.4 ARL Bio Pharma Revenue in BioPharma Service Business (2018-2023)
11.13.5 ARL Bio Pharma Recent Developments
11.14 West Pharmaceutical
11.14.1 West Pharmaceutical Company Details
11.14.2 West Pharmaceutical Business Overview
11.14.3 West Pharmaceutical BioPharma Service Introduction
11.14.4 West Pharmaceutical Revenue in BioPharma Service Business (2018-2023)
11.14.5 West Pharmaceutical Recent Developments
11.15 BioScreen
11.15.1 BioScreen Company Details
11.15.2 BioScreen Business Overview
11.15.3 BioScreen BioPharma Service Introduction
11.15.4 BioScreen Revenue in BioPharma Service Business (2018-2023)
11.15.5 BioScreen Recent Developments
11.16 Microbac
11.16.1 Microbac Company Details
11.16.2 Microbac Business Overview
11.16.3 Microbac BioPharma Service Introduction
11.16.4 Microbac Revenue in BioPharma Service Business (2018-2023)
11.16.5 Microbac Recent Developments
11.17 RD Laboratories
11.17.1 RD Laboratories Company Details
11.17.2 RD Laboratories Business Overview
11.17.3 RD Laboratories BioPharma Service Introduction
11.17.4 RD Laboratories Revenue in BioPharma Service Business (2018-2023)
11.17.5 RD Laboratories Recent Developments
11.18 Analytical Lab Group
11.18.1 Analytical Lab Group Company Details
11.18.2 Analytical Lab Group Business Overview
11.18.3 Analytical Lab Group BioPharma Service Introduction
11.18.4 Analytical Lab Group Revenue in BioPharma Service Business (2018-2023)
11.18.5 Analytical Lab Group Recent Developments
11.19 Piramal Pharma Solutions
11.19.1 Piramal Pharma Solutions Company Details
11.19.2 Piramal Pharma Solutions Business Overview
11.19.3 Piramal Pharma Solutions BioPharma Service Introduction
11.19.4 Piramal Pharma Solutions Revenue in BioPharma Service Business (2018-2023)
11.19.5 Piramal Pharma Solutions Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Eurofins
Pace Analytical Services
Catalent
Envigo
PPD
Element
ALS
Intertek
SGS
Boston Analytical
EAG
Maxxam
ARL Bio Pharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
听
听
*If Applicable.